vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Mirion Technologies, Inc. (MIR). Click either name above to swap in a different company.

Mirion Technologies, Inc. is the larger business by last-quarter revenue ($257.6M vs $134.9M, roughly 1.9× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 27.5%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 11.5%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Mirion Technologies, Inc. is a global provider of radiation detection, monitoring, and safety solutions. Its core offerings include personal dosimetry systems, radiation imaging equipment, and risk management software, serving nuclear power, healthcare, defense, and industrial sectors across North America, Europe, and the Asia Pacific.

CTRE vs MIR — Head-to-Head

Bigger by revenue
MIR
MIR
1.9× larger
MIR
$257.6M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+27.6% gap
CTRE
55.1%
27.5%
MIR
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
11.5%
MIR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CTRE
CTRE
MIR
MIR
Revenue
$134.9M
$257.6M
Net Profit
$111.3M
Gross Margin
46.2%
Operating Margin
1.4%
Net Margin
82.5%
Revenue YoY
55.1%
27.5%
Net Profit YoY
113.5%
EPS (diluted)
$0.52
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
MIR
MIR
Q1 26
$257.6M
Q4 25
$134.9M
$277.4M
Q3 25
$132.4M
$223.1M
Q2 25
$112.5M
$222.9M
Q1 25
$96.6M
$202.0M
Q4 24
$86.9M
$254.3M
Q3 24
$77.4M
$206.8M
Q2 24
$68.9M
$207.1M
Net Profit
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
$111.3M
$17.3M
Q3 25
$74.9M
$2.9M
Q2 25
$68.5M
$8.3M
Q1 25
$65.8M
$300.0K
Q4 24
$52.1M
$15.0M
Q3 24
$33.4M
$-13.6M
Q2 24
$10.8M
$-11.7M
Gross Margin
CTRE
CTRE
MIR
MIR
Q1 26
46.2%
Q4 25
48.8%
Q3 25
46.8%
Q2 25
46.0%
Q1 25
47.6%
Q4 24
48.1%
Q3 24
44.9%
Q2 24
47.0%
Operating Margin
CTRE
CTRE
MIR
MIR
Q1 26
1.4%
Q4 25
9.2%
Q3 25
58.1%
3.3%
Q2 25
61.3%
4.4%
Q1 25
4.3%
Q4 24
11.4%
Q3 24
43.0%
-0.8%
Q2 24
15.1%
1.1%
Net Margin
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
82.5%
6.2%
Q3 25
56.6%
1.3%
Q2 25
60.9%
3.7%
Q1 25
68.1%
0.1%
Q4 24
60.0%
5.9%
Q3 24
43.2%
-6.6%
Q2 24
15.6%
-5.6%
EPS (diluted)
CTRE
CTRE
MIR
MIR
Q1 26
$-0.01
Q4 25
$0.52
$0.07
Q3 25
$0.35
$0.01
Q2 25
$0.35
$0.03
Q1 25
$0.35
$0.00
Q4 24
$0.30
$0.08
Q3 24
$0.21
$-0.07
Q2 24
$0.07
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
MIR
MIR
Cash + ST InvestmentsLiquidity on hand
$198.0M
$397.9M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$1.9B
Total Assets
$5.1B
$3.5B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
MIR
MIR
Q1 26
$397.9M
Q4 25
$198.0M
$412.3M
Q3 25
$712.5M
$933.2M
Q2 25
$306.1M
$262.6M
Q1 25
$26.5M
$185.8M
Q4 24
$213.8M
$175.2M
Q3 24
$377.1M
$133.3M
Q2 24
$495.1M
$122.2M
Total Debt
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
$894.2M
Q3 25
$893.8M
$444.8M
Q2 25
$1.2B
$444.9M
Q1 25
$822.1M
$686.6M
Q4 24
$396.9M
$686.4M
Q3 24
$396.7M
$685.1M
Q2 24
$671.1M
$684.1M
Stockholders' Equity
CTRE
CTRE
MIR
MIR
Q1 26
$1.9B
Q4 25
$4.0B
$1.9B
Q3 25
$4.0B
$1.8B
Q2 25
$3.3B
$1.5B
Q1 25
$2.9B
$1.5B
Q4 24
$2.9B
$1.5B
Q3 24
$2.4B
$1.5B
Q2 24
$1.9B
$1.5B
Total Assets
CTRE
CTRE
MIR
MIR
Q1 26
$3.5B
Q4 25
$5.1B
$3.6B
Q3 25
$5.1B
$3.5B
Q2 25
$4.7B
$2.7B
Q1 25
$3.9B
$2.6B
Q4 24
$3.4B
$2.6B
Q3 24
$2.9B
$2.7B
Q2 24
$2.7B
$2.6B
Debt / Equity
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
0.22×
Q3 25
0.22×
0.24×
Q2 25
0.35×
0.30×
Q1 25
0.28×
0.46×
Q4 24
0.14×
0.46×
Q3 24
0.16×
0.45×
Q2 24
0.35×
0.45×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
MIR
MIR
Operating Cash FlowLast quarter
$394.0M
$18.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
MIR
MIR
Q1 26
$18.9M
Q4 25
$394.0M
$73.0M
Q3 25
$100.9M
$22.3M
Q2 25
$100.8M
$12.4M
Q1 25
$71.4M
$35.6M
Q4 24
$244.3M
$60.8M
Q3 24
$67.2M
$17.1M
Q2 24
$53.0M
$15.2M
Free Cash Flow
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
$63.2M
Q3 25
$13.0M
Q2 25
$3.6M
Q1 25
$27.1M
Q4 24
$49.1M
Q3 24
$3.9M
Q2 24
$4.1M
FCF Margin
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
22.8%
Q3 25
5.8%
Q2 25
1.6%
Q1 25
13.4%
Q4 24
19.3%
Q3 24
1.9%
Q2 24
2.0%
Capex Intensity
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
3.5%
Q3 25
4.2%
Q2 25
3.9%
Q1 25
4.2%
Q4 24
4.6%
Q3 24
6.4%
Q2 24
5.4%
Cash Conversion
CTRE
CTRE
MIR
MIR
Q1 26
Q4 25
3.54×
4.22×
Q3 25
1.35×
7.69×
Q2 25
1.47×
1.49×
Q1 25
1.08×
118.67×
Q4 24
4.68×
4.05×
Q3 24
2.01×
Q2 24
4.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

MIR
MIR

Product$197.0M76%
Service$60.6M24%

Related Comparisons